Medial temporal lobe function and associative memory formation in schizophrenia

Lead Research Organisation: University of Edinburgh
Department Name: Sch of Molecular. Genetics & Pop Health

Abstract

Schizophrenia is a common and severe psychiatric illness. Our work aims to understand more about the causes of this illness.
Recent studies have identified genes that are associated with risk for schizophrenia. These genes affect the cellular processes underlying learning and memory. We believe that alterations in simple learning processes can result in many of the problems seen in schizophrenia. We are therefore investigating how patients with schizophrenia and their relatives perform on basic learning tasks. We are also looking at their brain activity while carrying out these learning tasks using safe magentic resonance imaging (MRI) scanning technology to see if there are differences in brain activity between people with schizophrenia and healthy control participants.
We are in addition directly investigating how specific genes associated with schizophrenia, such as a gene called Neuregulin-1, cause the illness. In particular we are studying the effects that these genes have on brain structure and function as well as on learning processes and the development of symptoms.
We hope that understanding more about the basic causes of schizophrenia will eventually enable entirely novel treatments to be developed for this disabling mental health illness.

Technical Summary

Schizophrenia is a common and severe neuro-psychiatric disorder. One of the characteristic abnormalities in brain structure seen in schizophrenia is a reduction in volume of the medial temporal lobe (MTL). Reductions in MTL volume is also seen in the unaffected relatives of schizophrenic patients, suggesting that this may reflect genetic risk for the disorder. The MTL is required for associative learning underlying the formation of episodic and emotional memories, areas in which patients with schizophrenia show marked deficits. Schizophrenia susceptibility genes, such as Neuregulin-1 (NRG1) show convergent effects on molecular processes underlying associative memory formation. Furthermore studies in the local population have recently identified common variants in NRG1 associated with increased risk for schizophrenia. In this project I aim to:

(i) Investigate the performance of patients with schizophrenia and their first degree relatives in two behavioural tests of associative memory formation: face-name pair memory and Pavlovian conditioning.
(ii) Use functional magnetic imaging to investigate the activation of the MTL in patients and relatives performing these associative memory tasks.
(iii) Determine the impact of genetic variants in NRG1 on associative memory formation and MTL structure and activation.

These studies will directly investigate the basic neurobiological process of associative memory formation in schizophrenia, and will develop models in which to test the impact of genes conferring susceptibility to schizophrenia on associative memory formation. In addition this work will provide me with extensive training in the areas of functional imaging and psychiatric genetics.

Publications

10 25 50
 
Description Pfizer Grand Challenge Grant
Amount £1,037,764 (GBP)
Organisation Pfizer Ltd 
Sector Private
Country United Kingdom
Start  
 
Description Scottish Senior Clinical Fellowship
Amount £575,000 (GBP)
Organisation Chief Scientist Office 
Sector Public
Country United Kingdom
Start  
 
Description Translational Medicine Research Collaboration
Amount £195,646 (GBP)
Organisation Pfizer Ltd 
Department Wyeth Pharmaceuticals
Sector Private
Country United States
Start  
 
Description Translational Medicine Research Collaboration
Amount £242,375 (GBP)
Organisation Pfizer Ltd 
Department Wyeth Pharmaceuticals
Sector Private
Country United States
Start  
 
Title Conditioning paradigm 
Description This is an fMRI task which assesses brain activation related to specific psychotic symptoms. 
Type Of Material Model of mechanisms or symptoms - human 
Year Produced 2009 
Provided To Others? Yes  
Impact Ongoing research work which includes collaborations with Wyeth pharamceuticals (now Pfizer) examining potential use as a biomarker. 
 
Description Pfizer Grand Challenge Project 
Organisation Pfizer Ltd
Country United Kingdom 
Sector Private 
PI Contribution Design, implementation and recruitment of a large imaging an d genetic collaboration.
Collaborator Contribution techincal and research input
Impact Ongoing
Start Year 2010
 
Description Research Collaboration with Abbott Pharmaceuticals 
Organisation Abbott
Country United States 
Sector Private 
PI Contribution Generation of new imaging model for translational research
Collaborator Contribution Shared knowledge
Impact Collaboration ongoing
Start Year 2011
 
Description Translational Medicine Research Collaboration (includes Wyeth) 
Organisation Pfizer Ltd
Department Wyeth Pharmaceuticals
Country United States 
Sector Private 
PI Contribution For one of the collaborative projects I was PI and designed, submitted, implemented and analysed the work. FOr the second project I was Co-I and played a major role in the design and implementation of the work..
Collaborator Contribution Some technical discussions
Impact Work undertaken as part of my MRC Fellowship has led to the establishment of 2 collaborative grants with the Translational Medicine Research Collaboration (TMRC), in which Wyeth is a major stakeholder. This work develops the potential use of neuroimaging markers of medial temporal lobe function and associative memory formation as potential biomarkers for schizophrenia and for the development of medications aimed at cognitive enhancement. This additional funding has enabled me to expand the scope of the project to include larger numbers and additional clinical groups. This will also potentially facilitate future genetic analysis of the imaging data. Combined publications include a recent paper accepted in teh Archives of General Psychiatry.
Start Year 2008
 
Description Feedback to research participants 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Participants in your research and patient groups
Results and Impact A large feedback meeting was held for all research participants and interested parties at which the results of the research at that stage were presented. It is intended that future such meetings will also be held.

Positive feedback from participants.
Year(s) Of Engagement Activity 2007
 
Description Winter School in Psychiatry 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Undergraduate students
Results and Impact Talk titled '21st Century Psychiatry', aimed to encourage students into psychiatry  
Year(s) Of Engagement Activity 2016